
			Ernesto Bertarelli inherited biotech giant Serono, maker of the billion-dollar multiple sclerosis drug Rebif, following his father's death in 1998. Along with his sister Dona, he expanded the company to $2.4 billion in revenues before selling it to Merck for $9 billion in 2007. Ernesto and Dona run the Bertarelli Foundation, which focuses on marine conservation and life sciences research.  A yacht enthusiast, his Team Alinghi races in the Extreme Sailing Series and is a rival of fellow billionaire Larry Ellison. He also owns the $100 million superyacht Vava II. The family's Waypoint Group has investments ranging from commercial real estate in London to drug companies.
		